Form 8-K - Current report:
SEC Accession No. 0001640334-22-000444
Filing Date
2022-03-10
Accepted
2022-03-09 19:15:17
Documents
15
Period of Report
2022-03-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 25817
2 BYLAWS AMENDMENT artl_ex31.htm EX-3.1 4820
  Complete submission text file 0001640334-22-000444.txt   159981

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA artl-20220304.xsd EX-101.SCH 5837
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20220304_lab.xml EX-101.LAB 15274
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20220304_cal.xml EX-101.CAL 900
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20220304_pre.xml EX-101.PRE 9727
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20220304_def.xml EX-101.DEF 2105
9 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 3718
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 22726893
SIC: 2834 Pharmaceutical Preparations